中文 | English
Return
Total: 32 , 1/4
Show Home Prev Next End page: GO
MeSH:(Neoadjuvant Therapy/adverse effects*)

1.Neoadjuvant therapy in pancreatic cancer.

Jia-fu JI ; Zi-yu LI

Acta Academiae Medicinae Sinicae 2005;27(5):644-647

2.Efficacy and safety of neoadjuvant chemotherapy with modified FOLFOX7 regimen on the treatment of advanced gastric cancer.

Jun ZHANG ; Ren-Xiong CHEN ; Jing ZHANG ; Jun CAI ; Hua MENG ; Guo-Cong WU ; Zhong-Tao ZHANG ; Yu WANG ; Kang-Li WANG

Chinese Medical Journal 2012;125(12):2144-2150

3.Safety and efficacy of preoperative mFOLFOX6 regimen chemotherapy for locally resectable advanced rectal cancer.

Libing LIU ; Zhongjun JIANG

Journal of Central South University(Medical Sciences) 2021;46(1):32-38

4.Efficacy of neoadjuvant radiochemotherapy in treatment of locally advanced low rectal cancer.

Bao-Ming YU ; Min ZHANG ; Wei-Qin WU ; Li-Wen CHEN ; Jun FU ; Chun-Song FEI ; Ying SHEN

Chinese Journal of Surgery 2007;45(7):445-448

5.Efficacy and safety of SOX regimen as neoadjuvant chemotherapy for advanced gastric cancer.

Tao LI ; Lin CHEN

Chinese Journal of Gastrointestinal Surgery 2011;14(2):104-106

6.Clinical Outcome of Doublet and Triplet Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer.

Ju Seok KIM ; Sun Hyung KANG ; Hee Seok MOON ; Jae Kyu SUNG ; Hyun Yong JEONG ; Ji Young SUL

The Korean Journal of Gastroenterology 2016;68(5):245-252

7.Clinical features and risk factors of anastomotic leakage after radical esophagectomy.

Chuangui CHEN ; Zhentao YU ; Email: YUZHENTAO@HOTMAIL.COM. ; Qingwen JIN ; Xizeng ZHANG

Chinese Journal of Surgery 2015;53(7):518-521

8.Efficacy of neoadjuvant chemotherapy combined with bevacizumab versus neoadjuvant chemotherapy alone for Her2-negative breast cancer: a meta-analysis of randomized controlled clinical trials.

Rui HAN ; Guanying WANG ; Yujiao ZHANG ; Xinhan ZHAO

Journal of Zhejiang University. Medical sciences 2016;45(4):379-386

9.Postoperative complications and their influence on the prognosis factors in gastric cancer patients receiving neoadjuvant treatment.

Tong Bo WANG ; Qi Kun MAO ; Xiao Jie ZHANG ; Hong ZHOU ; Chun Guang GUO ; Ying Tai CHEN ; Dong Bing ZHAO

Chinese Journal of Gastrointestinal Surgery 2021;24(2):160-166

10.Efficacy and survival outcomes of dose-dense carboplatin plus paclitaxel as neoadjuvant chemotherapy for triple-negative breast cancer.

Yang LIU ; Meng XIU ; Xiang WANG ; Qing LI ; Jia Yu WANG ; Ying FAN ; Qiao LI ; Shan Shan CHEN ; Rui Gang CAI ; Hong Nan MO ; Fei MA ; Yang LUO ; Bing He XU ; Pin ZHANG

Chinese Journal of Oncology 2022;44(2):178-184

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 32 , 1/4 Show Home Prev Next End page: GO